SCTR hypermethylation is a diagnostic biomarker in colorectal cancer
Open Access
- 24 September 2020
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 111 (12) , 4558-4566
Abstract
Diagnostic markers for both colorectal cancer (CRC) and its precursor lesions are lacking. Although aberrant methylation of SCTR gene was observed in CRC, the diagnostic performance has not been evaluated. Therefore, this study aimed to assess and verify the diagnostic value of SCTR methylation of CRC and its precursor lesions through integrating the largest methylation data. The diagnostic performance of SCTR methylation was analyzed in the discovery set from The Cancer Genome Atlas (TCGA) CRC methylation data (N = 440), and verified in a large‐scale test set (N = 938) from the Gene Expression Omnibus (GEO). Targeted bisulfite sequencing analysis was developed and applied to detect methylation status of SCTR in our independent validation set (N = 374). Our findings revealed that SCTR gene was frequently hypermethylated at its CpG islands in CRC. In the TCGA discovery set, the diagnostic score was constructed using 4 CpG sites (cg01013590, cg20505223, cg07176264, cg26009192) and achieved high diagnostic performance (AUC = 0.964). In the GEO test set, the diagnostic score had robust diagnostic ability to distinguish CRC (AUC = 0.948) and its precursor lesions (AUC = 0.954) from normal samples. Moreover, hypermethylation of SCTR gene was also found in cell‐free DNA samples collected from CRC patients, but not in those from healthy controls. In the validation set, consistent results were observed using the targeted bisulfite sequencing array. Our study highlights that hypermethylation at CpG islands of SCTR gene is a potential diagnostic biomarker in CRCs and its precursor lesions.Keywords
This publication has 34 references indexed in Scilit:
- Colorectal cancer screening: a global overview of existing programmesGut, 2015
- Differences in DNA Methylation Signatures Reveal Multiple Pathways of Progression From Adenoma to Colorectal CancerGastroenterology, 2014
- Multitarget Stool DNA Testing for Colorectal-Cancer ScreeningNew England Journal of Medicine, 2014
- Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChipsEpigenetics, 2013
- Long range epigenetic silencing is a trans‐species mechanism that results in cancer specific deregulation by overriding the chromatin domains of normal cellsMolecular Oncology, 2013
- Primer3—new capabilities and interfacesNucleic Acids Research, 2012
- Epigenetics and colorectal cancerNature Reviews Gastroenterology & Hepatology, 2011
- Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of diseaseBritish Journal of Cancer, 2009
- The CpG Island Methylator Phenotype Correlates with Long-Range Epigenetic Silencing in Colorectal CancerMolecular Cancer Research, 2008
- Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome bandNature Genetics, 2006